Mental Health in Combat Veterans: Mechanisms, Screening, and Evidence-Based Treatment of PTSD and Comorbidity

Combat exposure in Vietnam and other conflicts is strongly associated with post-traumatic stress disorder (PTSD), a trauma- and stressor-related condition characterized by intrusive symptoms, persistent avoidance, negative alterations in cognition and mood, and hyperarousal. Although the term “PTSD” is commonly used, clinical care also emphasizes comorbidity—particularly depression, substance use disorder, and traumatic brain injury (TBI)—because these co-occurring problems amplify functional impairment and complicate treatment planning.

PTSD develops when an individual experiences actual or threatened death, serious injury, or sexual violence, followed by symptom persistence beyond typical stress reactions. Mechanistically, PTSD reflects maladaptive learning and threat processing. During trauma, extreme stress can dysregulate the hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous system, while also altering brain circuits involved in fear conditioning and extinction. Neurobiologically, PTSD is linked to abnormal functioning of the amygdala (heightened threat salience), medial prefrontal cortex (impaired top-down regulation), and hippocampus (contextual memory difficulties). Consequently, cues reminiscent of the trauma can trigger intense re-experiencing—such as intrusive memories, distressing dreams, flashbacks, and physiological reactivity.

Avoidance behaviors are not merely “coping”; they are entrenched behavioral strategies that reduce short-term distress but maintain long-term symptoms by preventing corrective learning. Avoidance may involve staying away from reminders, suppressing thoughts, or emotional numbing. Over time, avoidance contributes to persistent negative beliefs, diminished interest, detachment, and restricted affect—features captured under the cognition and mood domain. Hyperarousal manifests as sleep disturbance, irritability or anger outbursts, hypervigilance, exaggerated startle response, and concentration problems. These features reflect heightened baseline sympathetic activation and difficulty gating threat-related sensory input.

The clinical picture is further shaped by appraisal and meaning-making. Many patients interpret symptoms as ongoing danger, which increases rumination and reinforces fear circuitry. This cognitive-behavioral component helps explain why trauma-focused psychotherapies and symptom-specific cognitive interventions can yield durable improvements. Screening should be routine in veteran populations because subthreshold PTSD, delayed onset, and chronicity are common. Validated instruments include the PTSD Checklist for DSM-5 (PCL-5) and the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) for diagnostic confirmation and severity tracking. Clinicians also assess depression (e.g., PHQ-9), anxiety, substance use, and risk for suicidal ideation.

Evidence-based treatment typically combines psychotherapeutic and, when appropriate, pharmacologic strategies. First-line trauma-focused psychotherapy includes Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT). PE uses imaginal and in vivo exposure to reduce conditioned fear responses through habituation and extinction, while CPT targets maladaptive trauma-related beliefs (e.g., guilt, shame, permanently damaged identity). EMDR (Eye Movement Desensitization and Reprocessing) is another validated option that facilitates adaptive memory processing. When symptoms are severe, comorbid, or functional impairment is high, adjunctive stabilization strategies may precede trauma-focused work, but care should continue toward evidence-based trauma processing.

Pharmacotherapy may be indicated based on symptom severity, patient preference, comorbid conditions, and prior response. Selective serotonin reuptake inhibitors (SSRIs) such as sertraline and paroxetine, as well as the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine, have demonstrated efficacy for PTSD symptom reduction. Medication can help with core symptoms like hyperarousal, sleep, and mood, but it is generally not as effective as trauma-focused psychotherapy for achieving full remission; many patients benefit from combined approaches. Care must include monitoring for side effects, activation, and interactions with substance use.

Sleep interventions are crucial because insomnia worsens threat sensitivity and increases emotional dysregulation. Behavioral sleep strategies (stimulus control, sleep restriction adapted clinically, and sleep hygiene) can reduce insomnia severity. For persistent nightmares, imagery rehearsal therapy (IRT) has supportive evidence and targets nightmare content and response patterns.

A high-risk area is the intersection of PTSD with anger, interpersonal conflict, and substance use. Hyperarousal and fear-based threat appraisal can present as irritability or aggression, which may be misinterpreted socially as “anger issues” rather than neurobiologically grounded symptoms. Integrated treatment for substance use—alongside PTSD care—is often necessary, since alcohol or drug use can provide short-term relief while worsening sleep architecture, executive function, and overall trauma recovery.

The prognosis varies with symptom duration, comorbidities, access to treatment, social support, and ongoing stressors. Early identification and evidence-based care improve outcomes, and even chronic PTSD can respond when therapy is matched to the patient and barriers are addressed. In veteran care systems, routine screening, coordinated specialty mental health services, peer support, and careful follow-up are key elements of effective management.

Source: [DustOffVietnam]